•  
  •  
 

The Thai Journal of Pharmaceutical Sciences

Abstract

Many women suffer from excess facial hair since they regard this as a defect in their appearance. Recently, U.S. FDA has approved eflornithine HC1 13.9% topical cream (Vaniqa™) for the management of unwanted facial hair in women. Eflornithine or a-difl...

DOI

10.56808/3027-7922.2301

First Page

17

Last Page

25

Included in

Pharmacology Commons

Share

COinS